aescap.com aescap.com

aescap.com

Aescap Venture - - Accelerating European Science Companies and Products in the biomedical field

What we invest in. Biocartis announces early closing of its Initial Public Offering. Biocartis raises EUR 100 million in successful initial Public Offering. Biocartis fixes IPO price at top end of range. Accelerating future growth of medical ventures across Europe. Aescap Venture’s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.

http://www.aescap.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR AESCAP.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 13 reviews
5 star
8
4 star
0
3 star
4
2 star
0
1 star
1

Hey there! Start your review of aescap.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

2.1 seconds

CONTACTS AT AESCAP.COM

NDI ICT Solutions

MAF van Strien

Strawi●●●●●●aan 51

Ams●●●dam , NL, 1077XW

NL

31.0●●●●4120
31.0●●●●1901
do●●●●●●●●●●@ndims.nl

View this contact

NDI ICT Solutions

MAF van Strien

Strawi●●●●●●aan 51

Ams●●●dam , NL, 1077XW

NL

31.0●●●●4120
31.0●●●●1901
do●●●●●●●●●●@ndims.nl

View this contact

NDI ICT Solutions

MAF van Strien

Strawi●●●●●●aan 51

Ams●●●dam , NL, 1077XW

NL

31.0●●●●4120
31.0●●●●1901
do●●●●●●●●●●@ndims.nl

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2004 April 28
UPDATED
2014 July 19
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 20

    YEARS

  • 0

    MONTHS

  • 21

    DAYS

NAME SERVERS

1
ns0.ndi.nl
2
ns1.ndi.nl
3
ns3.ndi.nu
4
ns4.ndi.nu

REGISTRAR

PSI-USA, INC. DBA DOMAIN ROBOT

PSI-USA, INC. DBA DOMAIN ROBOT

WHOIS : whois.psi-usa.info

REFERRED : http://www.psi-usa.info

CONTENT

SCORE

6.2

PAGE TITLE
Aescap Venture - - Accelerating European Science Companies and Products in the biomedical field | aescap.com Reviews
<META>
DESCRIPTION
What we invest in. Biocartis announces early closing of its Initial Public Offering. Biocartis raises EUR 100 million in successful initial Public Offering. Biocartis fixes IPO price at top end of range. Accelerating future growth of medical ventures across Europe. Aescap Venture’s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.
<META>
KEYWORDS
1 aescap
2 news
3 about us
4 team
5 our investment approach
6 portfolio
7 working with us
8 investment criteria
9 how we work
10 careers
CONTENT
Page content here
KEYWORDS ON
PAGE
aescap,news,about us,team,our investment approach,portfolio,working with us,investment criteria,how we work,careers,investor,biocartis ipo,show more,welcome,ital
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Aescap Venture - - Accelerating European Science Companies and Products in the biomedical field | aescap.com Reviews

https://aescap.com

What we invest in. Biocartis announces early closing of its Initial Public Offering. Biocartis raises EUR 100 million in successful initial Public Offering. Biocartis fixes IPO price at top end of range. Accelerating future growth of medical ventures across Europe. Aescap Venture’s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.

INTERNAL PAGES

aescap.com aescap.com
1

Aescap Venture - all_news - Accelerating European Science Companies and Products in the biomedical field

http://www.aescap.com/index.php?p=all_news

ORPHAZYME: FDA grants Fast Track designation for the Phase III clinical investigation of arimoclomol as a treatment of Niemann-Pick disease type C. Biocartis strengthens biomarker portfolio for colorectal cancer. Avantium raises â 20M in a financing round led by PMV. Orphazyme's lead product arimoclomol shows promising data in another disease. 2016-06-16 ORPHAZYME: FDA grants Fast Track designation for the Phase III clinical investigation of arimoclomol as a treatment of Niemann-Pick disease type C.

2

Aescap Venture - home - Accelerating European Science Companies and Products in the biomedical field

http://www.aescap.com/index.php?p=home

ORPHAZYME: FDA grants Fast Track designation for the Phase III clinical investigation of arimoclomol as a treatment of Niemann-Pick disease type C. Biocartis strengthens biomarker portfolio for colorectal cancer. Avantium raises â 20M in a financing round led by PMV. Orphazyme's lead product arimoclomol shows promising data in another disease. We are investors in private life sciences companies. Aescap 1 is a venture capital fund which started investing in.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

2

LINKS TO THIS WEBSITE

tnbnews.com tnbnews.com

tnbnews.com - Hepatitis C Portfolio

http://tnbnews.com/content/view/16/45

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com - Advertise

http://tnbnews.com/content/view/12/35

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com

http://tnbnews.com/content/category/7/18/29

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com - Technology News

http://www.tnbnews.com/component/option,com_newsfeeds/catid,25/Itemid,41

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com

http://tnbnews.com/content/category/7/19/30

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com

http://tnbnews.com/content/category/7/17/28

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com - About TNB

http://tnbnews.com/content/view/13/36

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com - Vaccine Portfolio

http://www.tnbnews.com/content/view/17/46

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. Is Free Software released under the GNU/GPL License.

tnbnews.com tnbnews.com

tnbnews.com - Medical News

http://tnbnews.com/component/option,com_newsfeeds/catid,24/Itemid,40

Blood Proteins Add New Frontier. Leader Continue The Charge. Phase II Trials Underway. Innovation Knows No End. Phase III Results Due Soon. New Phone Outsmarts Razor. The New England Journal of Medicine. International Journal of Obesity. Cell Death and Differentation AOP. Cancer Gene Therapy AOP. British Journal of Pharmacology AOP. British Journal of Cancer AOP. Bone Marrow Transplantation AOP. Is Free Software released under the GNU/GPL License.

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL LINKS TO THIS WEBSITE

23

OTHER SITES

aescans.com aescans.com

aescans.com

This domain is listed at Mark.com. Welcome to aescans.com.

aescantabria.blogspot.com aescantabria.blogspot.com

ALTERNATIVA ESPAÑOLA CANTABRIA

Desde la concepción finalista y cristiana que inspira nuestra forma de entender la vida y la política, hemos considerado que la tarea que nos hemos impuesto no debe venir determinado sólo por unos resultados electorales, sino por la defensa de los pilares de la Fe y de la Patria" (Rafael López-Diéguez). Martes, 5 de mayo de 2015. AES presenta 24 candidatos a las elecciones municipales en tres candidaturas en Cantabria. Jueves, 19 de febrero de 2015. Reunidos con Miguel Bernad, los editores del YA, Santia...

aescantabria.es aescantabria.es

Asociación de estaciones de servicio de Cantabria

Asociación Regional de Empresarios de Estaciones de Servicio de Cantabria. Avda de los Castros, 35 2º C. Teléfono: 942 278 600. Fax: 942 274 729. Localización en el mapa. Domingo, 17 de mayo de 2015 - 16:09. Te encuentras en la pagina web de la Asociacion Regional de Empresarios de Estaciones de Servicio de Cantabria, que se creó hace más de 40 años, en nuestra región representamos al 98% de los empresarios Independientes de nuestro sector en nuestra comunidad. Además mediamos en las cuestiones que se su...

aescantech-pdox.com aescantech-pdox.com

Non-Existent Domain

Your browser does not support iframes, please click here.

aescap.com aescap.com

Aescap Venture - - Accelerating European Science Companies and Products in the biomedical field

What we invest in. Biocartis announces early closing of its Initial Public Offering. Biocartis raises EUR 100 million in successful initial Public Offering. Biocartis fixes IPO price at top end of range. Accelerating future growth of medical ventures across Europe. Aescap Venture’s added value is based on a multi-disciplinary team of experienced investment partners. Each has a proven track record of success and the skills to coach entrepreneurs in accelerating the growth of their companies.

aescapacitacion.com.ar aescapacitacion.com.ar

AES |Cursos online y presencial con rápida Salida Laboral|clic aquí

Córdoba Argentina CP 5000. San Martín 119 1er piso oficina 6. Ofertas laborales para egresados. Página oficial en facebook.

aescape.com aescape.com

www.aescape.com

aescape.wordpress.com aescape.wordpress.com

aescape | [aesthetics+escapism]

Apologies, but no results were found for the requested archive. Perhaps searching will help find a related post. Blog at WordPress.com. Follow “aescape”. Get every new post delivered to your Inbox. Join 89 other followers. Build a website with WordPress.com.

aescapharm.com aescapharm.com

aescapharm.com | Hello, this domain has been purchased at Hostpoint

We're glad that you purchased your desired domain from us. Thank you! Now all that's left is to quickly set up a nice website. Not quite there yet? No worries – we'll take care of it. Hostpoint is glad to handle your web hosting. We offer a flexible, all-in-one package for all e-mail and web projects – tailored to your exact requirements. And with a unique, flexible Control Panel that gives you convenient access to your server at all times. Still don't have your own website, you say?

aescapia.com aescapia.com

home [AESCAPIA AB]

FAQ Hollow Ground SE. Stray Hero - coming soon. Posted by Jonas Ledendal 01/15/2009. Stray Hero is a casual RPG in development by Grym Games. The game will be released on Windows, Mac and Linux when it’s done. Stray Hero has been developed by some of the original Hollow Ground team members. We’ll tell you more when the time is right! Hollow Ground for Windows (beta). Posted by Jonas Ledendal 09/13/2008. Independent game developer Blackwight. Download Hollow Ground for Windows. Hollow Ground SE Released.